Addressing a Major Unmet Medical Need
Cardiovascular diseases (CVD) are the leading cause of death and disability worldwide. Despite varying causes, the resulting damage almost always stems from endothelial dysfunction and vascular injury—leading to impaired blood flow, inflammation, tissue necrosis, and functional decline.
Current gap:
No long-term oral therapies exist that directly address this vascular dysfunction.
Our solution:
A novel oral STS tablet designed to protect and restore the vascular wall.
